Delivery Order SPE2DB22D3501-SPE2DB25FWE70
Award Date
6/26/25
Potential Completion Date
6/27/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $5,231.80 firm fixed-price contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The award has an ultimate completion date of August 28, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,375.09, is for the delivery of 100 units of the prescription medication VYVANSE 40 MG CAPSULE. The contract has a firm fixed price pricing type and a completion date of July 2, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
This is a $1,825.65 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of 4568677829 VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a completion date of July 1, 2025 and was awarded on June 30, 2025. This delivery order contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,265,916 units of the medication VYVANSE 10 MG CAPSULE 100S, with a ceiling value of $1,320.90. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) with a period of performance through July 29, 2024. Amerisourcebergen is not operating under a set-aside designation for this award. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication, with a ceiling value of $2,142.14 and a performance period ending on June 26, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,264.18 firm fixed-price contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication. The award is not set-aside and has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $2,701.39. The contract is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription medication. The contract is not set aside and has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide VYVANSE 30 MG CAPSULE 100S. The contract has a firm fixed price of $1,587.90 and a period of performance through July 1, 2025. This delivery order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.59 firm fixed-price contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.61 firm fixed-price contract is for the delivery of 4,567,612,803 units of the prescription medication VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...